Xenetic Biosciences, Inc. Quarterly Return On Equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xenetic Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q3 2024.
  • Xenetic Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -49.5 %, a 37.1% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2023 was -36.4 %, a 16.3% increase from 2022.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2022 was -43.5 %, a 14.5% decline from 2021.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2021 was -38 %, a 54.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -49.5 -13.4 -37.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -51 -19.3 -60.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -43.4 -2.01 -4.86% Jan 1, 2024 Mar 31, 2024
Q4 2023 -36.4 +7.07 +16.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -36.1 +6.43 +15.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -31.7 +10.5 +24.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -41.4 -5.35 -14.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -43.5 -5.5 -14.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.5 -4.95 -13.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -42.2 +67.1 +61.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36 +59.3 +62.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -38 +46.3 +54.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -37.6 +39.1 +51% Jul 1, 2021 Sep 30, 2021
Q2 2021 -109 -36.5 -50.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -95.3 -13.9 -17.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -84.3 +4.74 +5.32% Oct 1, 2020 Dec 31, 2020
Q3 2020 -76.7 +29.1 +27.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -72.8 -15.7 -27.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -81.4 -21.6 -36.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -89.1 -26.8 -43% Oct 1, 2019 Dec 31, 2019
Q3 2019 -106 -96.3 -1015% Jul 1, 2019 Sep 30, 2019
Q2 2019 -57.1 -43.7 -326% Apr 1, 2019 Jun 30, 2019
Q1 2019 -59.8 -38.7 -183% Jan 1, 2019 Mar 31, 2019
Q4 2018 -62.3 -33.1 -113% Oct 1, 2018 Dec 31, 2018
Q3 2018 -9.49 +56.5 +85.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -13.4 +59.4 +81.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -21.2 +483 +95.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -29.2 +616 +95.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -66 +890 +93.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -72.8 +964 +93% Apr 1, 2017 Jun 30, 2017
Q1 2017 -504 -274 -119% Jan 1, 2017 Mar 31, 2017
Q4 2016 -645 -459 -246% Oct 1, 2016 Dec 31, 2016
Q3 2016 -956 -784 -457% Jul 1, 2016 Sep 30, 2016
Q2 2016 -1.04K -925 -828% Apr 1, 2016 Jun 30, 2016
Q1 2016 -230 -129 -128% Jan 1, 2016 Mar 31, 2016
Q4 2015 -186 -93.8 -101% Oct 1, 2015 Dec 31, 2015
Q3 2015 -172 -109 -172% Jul 1, 2015 Sep 30, 2015
Q2 2015 -112 Apr 1, 2015 Jun 30, 2015
Q1 2015 -101 Jan 1, 2015 Mar 31, 2015
Q4 2014 -92.6 Oct 1, 2014 Dec 31, 2014
Q3 2014 -63.1 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.